Survival outcomes, treatment toxicity, and healthcare utilization in older adults with aggressive non-Hodgkin lymphoma (NHL).

Authors

null

Mitchell W. Lavoie

Massachusetts General Hospital, Boston, MA

Mitchell W. Lavoie , Alisha Yi , Ryan David Nipp , Nora K. Horick , Hermioni L. Amonoo , Richard Newcomb , Julia Rice , Matthew J. Reynolds , Areej El-Jawahri , Patrick Connor Johnson

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia

Track

Hematologic Malignancies

Sub Track

Non-Hodgkin Lymphoma

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr 7557)

DOI

10.1200/JCO.2021.39.15_suppl.7557

Abstract #

7557

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

Poster

2016 Palliative and Supportive Care in Oncology Symposium

Contribution of polypharmacy and potentially inappropriate medication use to inferior survival in older patients with aggressive lymphoma.

Contribution of polypharmacy and potentially inappropriate medication use to inferior survival in older patients with aggressive lymphoma.

First Author: Richard Jirui Lin

First Author: George Slade Mellgard

First Author: Leah Mailly-Giacchetti